U.S.-China Collaboration Could Cut Development Time, Cost For New Cancer Treatments

The world’s current system for developing cancer drugs is unsustainable, Memorial Sloan Kettering oncologist Dr. Bob Li believes.

Read the full post on Forbes - Healthcare

Russell Flannery, Forbes Staff